Keywords: ardana, fiscal, loss, per, share, widens, scottish
Ardana's fiscal 2007 loss per share widens 28.6%
Article | 09 July 2007
Scottish drugmaker Ardana says that total revenues from product sales for the year ended March 31, 2007, were L240,000 ($449,016) versus L384,000 in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
